Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 3030.00, down by 50.65 points or 1.64% from its previous closing of Rs. 3080.65 on the BSE.

The scrip opened at Rs. 3085.00 and has touched a high and low of Rs. 3117.30 and Rs. 2996.00 respectively. So far 50677 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3353.85 on 25-Sep-2014 and a 52 week low of Rs. 2250.00 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 3185.00 and Rs. 2990.00 respectively. The current market cap of the company is Rs. 52336.39 crore.

The promoters holding in the company stood at 25.49 % while Institutions and Non-Institutions held 43.79 % and 13.69 % respectively.

Dr. Reddys Laboratories has reported 43.94% fall in its net profit at Rs 433.59 crore for the quarter under review as compared to Rs 773.38 crore for the same quarter in the previous year. Total income of the company has decreased 7.48% at Rs 2535.62 crore for Q2FY15 as compared Rs 2740.90 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit for the quarter under review declined 16.83% at Rs 574.10 crore against Rs 690.25 crore in the September quarter of previous fiscal. However, the company’s total income has increased by 5.65% at Rs 3614.37 crore for the quarter from Rs 3421.12 crore in the similar quarter of previous year.